Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2021-01-28 Major Shareholding Noti…
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-28 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 13, 2021, reporting preliminary revenue results for the quarter and year ended December 31, 2020. It includes a press release as Exhibit 99.1. The content is a current report announcing financial results, specifically preliminary revenue figures, which aligns with an Earnings Release. The document length is 3599 characters, which is relatively short but contains substantive financial information rather than just an announcement of a report. Therefore, it is classified as an Earnings Release (ER).
2021-01-13 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 5, 2020. It reports an event related to an increase in annual cash compensation for the Chair of the Regulatory Compliance Committee of the Board. The content focuses on a board decision regarding compensation, which is a management/board-related announcement. The document is short (3176 characters) and does not contain financial statements or detailed financial data. It is not an earnings release, annual report, or other financial report. It is not a proxy statement or remuneration report but rather an announcement of a board decision on compensation. Therefore, the most appropriate classification is Board/Management Information (MANG).
2020-11-12 English
10-Q
Interim / Quarterly Report 9M 2020
2020-11-09 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 9, 2020, reporting the results of operations for the third fiscal quarter ended September 30, 2020. It specifically mentions an attached earnings press release (Exhibit 99.1) and describes the content as a press release reporting quarterly financial results. The document is relatively short (3554 characters) and is primarily an announcement of the earnings release rather than the full financial report itself. According to the definitions, an initial announcement of quarterly financial results (key highlights only) corresponds to an Earnings Release (ER). Therefore, this document should be classified as an Earnings Release (ER).
2020-11-09 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated September 16, 2020, for Apyx Medical Corporation. The content focuses on the announcement of amended and restated employment agreements for key executives, including the CEO, CFO, and Executive Vice President. It details terms of employment, compensation, termination provisions, and other contractual elements related to senior management. There is no financial data, earnings information, or report publication mentioned. The primary subject is changes and updates to senior management employment agreements, which aligns with announcements about board or management changes. Therefore, the document fits best under the category for Board/Management Information (MANG). The document length is substantial (15,000 characters), indicating it is not a brief announcement or certification but a detailed disclosure of management agreements.
2020-09-18 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.